The CD9 tetraspanin is not required for the development of peripheral B cells or for humoral immunity

Journal of Immunology

Volumn 175, Issue 5, 2005, Pages 2925-2930

  Cariappa, Annaiah ^a   Shoham, Tsipi ^b   Liu, Haoyuan ^a   Levy, Shoshana ^b   Boucheix, Claude ^c   Pillai, Shiv ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HÔPITAL PAUL BROUSSE   (France)

^d MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRUTON TYROSINE KINASE; CD1D ANTIGEN; CD9 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN D; TETRASPANIN;

ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CELL SUBPOPULATION; CELL SURVIVAL; CONTROLLED STUDY; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; SPLEEN;

EID: 23844516999     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.5.2925     Document Type: Article

References (35)

1. Maecker, H. T., S. C. Todd, and S. Levy. 1997. The tetraspanin superfamily: molecular facilitators. FASEB J. 11: 428-442.
2. Hemler, M. E. 2003. Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu. Rev. Cell. Dev. Biol. 19: 397-422.
3. Boucheix, C., and E. Rubinstein. 2001. Tetraspanins. Cell. Mol. Life Sci. 58: 1189-1205.
4. Levy, S., S. C. Todd, and H. T. Maecker. 1998. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu. Rev. Immunol. 16: 89-109.
5. Oren, R., S. Takahashi, C. Doss, R. Levy, and S. Levy. 1990. TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol. Cell. Biol. 10: 4007-4015.
6. Maecker, H. T., and S. Levy. 1997. Normal lymphocyte development but delayed humoral immune response in CD81-null mice. J. Exp. Med. 185: 1505-1510.
7. Le Naour, F., E. Rubinstein, C. Jasmin, M. Prenant, and C. Boucheix. 2000. Severely reduced female fertility in CD9-deficient mice. Science 287: 319-321.
8. Tachibana, I., J. Bodorova, F. Berditchevski, M. M. Zutter, and M. E. Hemler. 1997. NAG-2, a novel transmembrane-4 superfamily (TM4SF) protein that complexes with integrins and other TM4SF proteins. J. Biol. Chem. 272: 29181-29189.
9. Miyake, M., M. Koyama, M. Seno, and S. Ikeyama. 1991. Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J. Exp. Med. 174: 1347-1354.
10. 1 integrin and the neural adhesion molecule Ll. J. Neurosci. Res. 43: 12-31.
11. Miyake, M., K. Nakano, Y. Ieki, M. Adachi, C. L. Huang, S. Itoi, T. Koh, and T. Taki. 1995. Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer. Cancer Res. 55: 4127-4131.
12. Higashiyama, M., T. Taki, Y. Ieki, M. Adachi, C. L. Huang, T. Koh, K. Kodama, O. Doi, and M. Miyake. 1995. Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer. Cancer Res. 55: 6040-6044.
13. Miyake, M., K. Nakano, S. I. Itoi, T. Koh, and T. Taki. 1996. Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer. Cancer Res. 56: 1244-1249.
14. Miyake, M., H. Inufusa, M. Adachi, H. Ishida, H. Hashida, T. Tokuhara, and Y. Kakehi. 2000. Suppression of pulmonary metastasis using adenovirally motility related protein-1 (MRP-1/CD9) gene delivery. Oncogene 19: 5221-5226.
15. Mori, M., K. Mimori, T. Shiraishi, M. Haraguchi, H. Ueo, G. F. Barnard, and T. Akiyoshi. 1998. Motility related protein 1 (MRP1/CD9) expression in colon cancer. Clin. Cancer Res. 4: 1507-1510.
16. Won, W. J., and J. F. Kearney. 2002. CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice. J. Immunol. 168: 5605-5611.
17. Lu, T. T., and J. G. Cyster. 2002. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 297: 409-412.
18. Martin, F., and J. F. Kearney. 2000. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity 12: 39-49.
19. Guinamard, R., M. Okigaki, J. Schlessinger, and J. V. Ravetch. 2000. Absence of marginal zone B cells in Pyk-2 deficient mice defines their role in the humoral response. Nat. Immunol. 1: 31-36.
20. Girkontaite, I., K. Missy, V. Sakk, A. Harenberg, K. Tedford, T. Potzel, K. Pfeffer, and K. D. Fischer. 2001. Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nat. Immunol. 2: 855-862.
21. Fukui, Y., O. Hashimoto, T. Sanui, T. Oono, H. Koga, M. Abe, A. Inayoshi, M. Noda, M. Oike, T. Shirai, and T. Sasazuki. 2001. Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration. Nature 412: 826-831.
22. Liu, Y. J., J. E. Lortan, S. Oldfield, and I. C. MacLennan. 1988. CBA/N mice have marginal zone B cells with normal surface immunoglobulin phenotype. Adv. Exp. Med. Biol. 237: 105-111.
23. high B cells: a population of mixed origin. Eur. J. Immunol. 29: 3285-3294.
24. Cariappa, A., M. Tang, C. Parng, E. Nebelitskiy, M. Carroll, K. Georgopoulos, and S. Pillai. 2001. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 14: 603-615.
25. Cariappa, A., T. J. Kim, and S. Pillai. 1999. Accelerated emigration of B lymphocytes in the Xid mouse. J. Immunol. 162: 4417-4423.
26. Shoham, T., R. Rajapaksa, C. Boucheix, E. Rubinstein, J. C. Poe, T. F. Tedder, and S. Levy. 2003. The tetraspanin CD81 regulates the expression of CD19 during B cell development in a postendoplasmic reticulum compartment. J. Immunol. 171: 4062-4072.
27. Hardy, R. R., K. Hayakawa, D. R. Parks, and L. A. Herzenberg. 1983. Demonstration of B cell maturation in X-linked immunodeficient mice by simultaneous three colour immunofluorescence. Nature 306: 270-272.
28. Rolink, A., and F. Melchers. 1991. Molecular and cellular origins of B lymphocyte diversity. Cell 66: 1081-1094.
29. Hardy, R. R., Y. S. Li, D. Allman, M. Asano, M. Gui, and K. Hayakawa. 2000. B-cell commitment, development and selection. Immunol. Rev. 175: 23-32.
30. Franzoso, G., L. Carlson, L. Poljak, E. W. Shores, S. Epstein, A. Leonardi, A. Grinberg, T. Tran, T. Scharton-Kesten, M. Anver, et al. 1998. Mice deficient in NFκB/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J. Exp. Med. 187: 147-159.
31. Cariappa, A., and S. Pillai. 2002. Antigen-dependent B-cell development. Curr. Opin. Immunol. 14: 241-249.
32. Pillai, S., A. Cariappa, and S. T. Moran. 2004. Positive selection and lineage commitment during peripheral B-lymphocyte development. Immunol. Rev. 197: 206-218.
33. Saito, T., S. Chiba, M. Ichikawa, A. Kunisato, T. Asai, K. Shimizu, T. Yamaguchi, G. Yamamoto, S. Seo, K. Kumano, et al. 2003. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity 18: 675-685.
34. Pillai, S., Cariappa, A., and Moran, S. T. 2005. Marginal zone B cells. Annu. Rev. Immunol. 23: 161-196.
35. Vinuesa, C. G., Y. Sunners, J. Pongracz, J. Ball, K. M. Toellner, D. Taylor, I. C. MacLennan, and M. C. Cook. 2001. Tracking the response of Xid B cells in vivo: T1-2 antigen induces migration and proliferation but Btk is essential for terminal differentiation. Eur. J. Immunol. 31: 1340-1350.